PARKE DAVIS FDA Approval NDA 020417

NDA 020417

PARKE DAVIS

FDA Drug Application

Application #020417

Application Sponsors

NDA 020417PARKE DAVIS

Marketing Status

Discontinued001

Application Products

001FILM, EXTENDED RELEASE;TRANSDERMAL0.025MG/24HR0FEMPATCHESTRADIOL

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1996-12-03STANDARD
LABELING; LabelingSUPPL2AP1998-06-17STANDARD

Submissions Property Types

SUPPL1Null0

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20417
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.